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Introduction
Respiratory physiotherapy is considered integral to the
management of patients in the intensive care unit (ICU). The
goals of physiotherapy are to optimise oxygen transport,
improve ventilation-perfusion matching, increase lung
volumes, reduce work of breathing, and enhance mucociliary
clearance (Ciesla 1996, Stiller 2000). Most ICU studies have
investigated the short-term effects of multimodality
physiotherapy on pulmonary function in intubated patients
receiving mechanical ventilation (Mackenzie et al 1980,
Mackenzie and Shin 1985, Stiller et al 1990).
As new therapeutic modalities emerge to treat ICU patients,
there is a need to investigate the effect of respiratory
physiotherapy techniques in patients receiving these
applications. One of these new approaches is non-invasive
ventilation (NIV), which has been increasingly and
successfully used in the treatment of acute respiratory failure
(Anton et al 2000, Brochard et al 1995, Carlucci et al 2001,
Celikel et al 1998). A number of techniques including
positioning, flutter, positive expiratory pressure (PEP)
therapy, and the active cycle of breathing techniques (ACBT)
have been suggested for patients undergoing NIV (Bott et al
2001). In a few NIV studies respiratory physiotherapy was
described as a part of standard medical treatment (Anton et al
2000, Bott et al 1993, Conway et al 1993) but no information
was given about the characteristics of patients receiving
physiotherapy, or the techniques applied to them. To our
knowledge, there is only one controlled study investigating
the effects of a respiratory physiotherapy technique in
patients with acute respiratory failure receiving NIV. Bellone
et al (2002) showed favourable results with the use of a PEP
mask in patients with acute exacerbation of chronic
obstructive pulmonary disease.
ACBT is one of the techniques that can be used in patients
receiving NIV. It requires active participation of the patients
but does not require a device such as a PEP mask. It can be
adapted easily to patients with different disease states (Pryor
and Webber 2002). It is an effective treatment in improving
pulmonary function (Savci et al 2000, Verboon et al 1986,
Webber et al 1986) and airway clearance (Pryor et al 1979,
Wilson et al 1995). It has been evaluated in stable patients
with cystic fibrosis (Pryor et al 1979, Verboon et al 1986,
Webber et al 1986) and chronic obstructive pulmonary
disease (Savci et al 2000). However, there is only one case
report related to its use in ICU showing that the ACBT
prevented the need for intubation in a patient with acute
respiratory failure (Wong 2000). Therefore, we performed a
prospective randomised controlled study to test the
hypothesis that applying the ACBT in patients with acute
hypercapnic respiratory failure receiving NIV would improve
patient outcome. In our study, the primary outcome measure
was length of time in need of NIV, and secondary outcome
measures were changes in acute physiology score and arterial
blood gas values, total duration of NIV, need for intubation,
mortality, and length of stay in the ICU.
Method
Subjects The study was conducted in a 9-bed medical ICU of
a university hospital, for an 18-month period between
November 2000 and May 2002. The study protocol was
approved by the Institute of Health Sciences. All patients with
acute hypercapnic respiratory failure in need of NIV, as
judged by the attending physician, were included in the study.
Acute hypercapnic respiratory failure was defined as an
arterial blood pH < 7.35 and an arterial carbon dioxide
pressure (PaCO
2
) > 45 mmHg (Grippi 1998). Exclusion
criteria were a need for immediate life-saving endotracheal
intubation, intubation prior to admission to the ICU, facial
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deformity, haemodynamic instability, inability to protect the
airway, extreme agitation, and unco-operativeness. Eligible
patients were allocated randomly, using file numbers, to
receive either ACBT and NIV (ACBT group) or NIV alone
(control group) by the physiotherapy team. The NIV
application, all other patient care, and measurements were
provided by the primary ICU team. The attending physician
took the decisions related to NIV management, and
physiotherapists were involved only the decisions related to
the application of the ACBT.
Measurements Patient demographics, home oxygen use, co-
morbid illnesses, and cause of respiratory failure were
recorded. Lung function data were noted if these had been
measured while the patient was clinically stable within the
preceding year. Body mass index was calculated. Pre-morbid
activities of daily living were recorded according to the
information taken from patients or relatives, and scored on a
5-point scale from 0 = working, to 4 = bed- or chair-bound
(Menzies et al 1989).
Heart rate, blood pressure, respiratory rate, arterial blood gas
values, chest radiographs, white blood cell and platelet
counts, haemoglobin and serum albumin level, and Glasgow
Coma Score were recorded on admission. The Acute
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Figure 2. Changes in arterial carbon dioxide pressure
(PaCO2) from admission to discharge in the active cycle of
breathing techniques (ACBT) and control groups. = ACBT
group, ■ = control group, M = morning, A = afternoon. Data
are means and standard deviations.
Ventilator




PSV, BiPAP or PCV 
Initial settings
Tidal volume >350 ml
Respiratory rate < 30-35 breaths/min
FiO2 for SpO2 > 90-92%
PEEP = 3-4 cmH2O
1. Clinical tolerance
2. Apnea, air leaks
3. Complications (nasal pressure sores, gastric distension, eye irritation, nasal bleeding)
4. Intubation criteria
5. Continuous SpO2
6. Arterial blood gas values
- Almost continuous non-invasive ventilation during the first 24 hours, with intermittent
interruption for oral intake, expectoration, bronchodilator treatment, and respiratory
physiotherapy (only in the ACBT group)
- Afterwards, daytime intermittent periods of non-invasive ventilation, gradually increased
spontaneous breathing periods with nasal oxygen, and nocturnal ventilation if possible.
- Stop non-invasive ventilation, when clinical stability achieved and spontaneous
breathing periods with nasal oxygen during 24 hours allow a daytime PaO2 ≥ 60 mmHg
with a PaCO2 ≤ 45 mmHg and pH ≥ 7.35.
Figure 1. Clinical application of non-invasive ventilation. ICU = intensive care unit, PSV = pressure support ventilation, PCV =
pressure control ventilation, FiO2 = fraction of inspired oxygen, SpO2 = oxygen saturation, PEEP = positive end–expiratory pressure,

















































Physiology and Chronic Health Evaluation II (APACHE II)
score was calculated in the first 24 hours of admission (Knaus
et al 1985). The acute physiology score in the last 24 hours of
ICU stay was also calculated (Knaus et al 1985). Morning
(0800) and afternoon (1600) arterial blood gas values, and
ventilator parameters were noted from the ICU flow sheet.
Total duration of NIV (the sum of hours in which patient was
on NIV), length of time in need of NIV (the total length of
time in days until the patient was not on NIV during the day
at all), length of ICU stay, need for intubation, and mortality
were recorded. In the ACBT group heart rate, blood pressure,
respiratory rate, oxygen saturation (SpO
2
) before and after the
application were recorded. Change in fraction of inspired
oxygen (FiO
2
) during the application, and the duration of
treatment for a single session were also recorded.
Non-invasive ventilation The NIV was applied by BiPAP(a) or
by ICU ventilator(b) with a commercially available full face
mask (Meduri and Spencer 2001, Mehta and Hill 2001).
Initial ventilatory settings were adjusted according to patient
tolerance, clinical monitoring, and arterial blood gas
measurements. First line ventilatory mode was pressure
support ventilation with external positive end-expiratory
pressure, or BiPAP. In the case of air leak or apnoea, pressure
control ventilation was used as a mode of choice (Meduri and
Spencer 2001). Ventilatory support was continued according
to the strategy described in Figure 1 (Anton et al 2000,
Celikel et al 1998, Mehta and Hill 2001, Meduri and Spencer
2001). The patients were discharged from the ICU if they
were clinically stable 24–72 hours after the completion of the
NIV. Failure of NIV was defined as the need for intubation or
death causally related to NIV. The criteria for intubation were
respiratory arrest, haemodynamic instability and/or severe
cardiac arrhythmias, severe agitation, and altered mental
status.
Active cycle of breathing techniques Respiratory
physiotherapy was applied by using the ACBT (Pryor and
Webber 2002) to all patients by the same respiratory
physiotherapist who had 10 years experience in the clinical
application of the technique. The ACBT consisted of 4–6
breathing control breaths, 3–4 thoracic expansion exercises,
and the forced expiration technique including 4–6 breathing
control breaths combined with 2–3 huffs (Pryor and Webber
2002). If there were copious or viscous secretions, ineffective
cough or huff, coarse crackles on auscultation, then chest
percussion and shaking were combined with thoracic
expansion exercises (Bott et al 2001, Pryor and Webber
2002).
The ACBT was applied once per day during the ICU stay.
Patients were not instructed nor encourged to perform the
ACBT independently of the physiotherapist. Ventilatory
assistance was not used, and oxygen treatment was continued
during the ACBT application. Duration of the ACBT in a
single session was determined according to affected side(s) of
the lung and patient tolerance, and was kept between 15 and
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Table 1. Characteristics and admission findings of the patients.
ACBT Control
(n = 17) (n = 17) p value
Age (years) 65 ± 8 65 ± 13 0.59
Sex Male:Female 8:9 4:13 0.14
Body mass index (kg/m2) 30 ± 8 26 ± 7 0.33
Smoking (pack-years) 31 ± 32 18 ± 24 0.24
APACHE II score 18.3 ± 3.6 19.3 ± 4.2 0.52
Acute physiology score 9.3 ± 2.8 10.3 ± 3.4 0.58
Heart rate (beats/min) 105 ± 17 98 ± 19 0.30
Mean arterial pressure (mmHg) 93 ± 14 92 ± 16 0.97
Respiratory rate (breaths/min) 31 ± 3 30 ± 6 0.64
PaCO2 (mmHg) 77.7 ± 11.1 77.3 ± 13.5 0.88
pH 7.27 ± 0.05 7.27 ± 0.05 0.63
PaO2/FiO2 ratio 273 ± 155 259 ± 104 0.77
Cor pulmonale 5 (29%) 3 (18%) 0.34
Co-morbidities 16 (94%) 15 (88%) 0.50
Home oxygen therapy 3 (18%) 3 (18%) 1.00
ADL prior to admission 1.8 ± 0.8 1.8 ± 0.8 1.00
Data are means ± SD or n (%). ACBT = active cycle of breathing techniques, APACHE = Acute Physiology and Chronic Health
Evaluation, PaCO2 = arterial carbon dioxide pressure, PaO2/FiO2 = ratio of arterial oxygen pressure to fraction of inspired oxygen,
ADL = activities of daily living.
Table 2. Causes of respiratory failure.
ACBT Control
(n = 17) (n = 17)
COPD, acute exacerbation 5 (29%) 11 (65%)
COPD, pneumonia 3 (18%) 3 (18%)
COPD, bronchiectasis, pneumonia 3 (18%) 2 (12%)
Previous pneumonectomy, pneumonia 2 (12%) 0
Bronchial asthma, pneumonia 1 (6%) 1 (6%)
Bronchiectasis, ankylosing spondilitis 1 (6%) 0
Interstitial lung disease 1 (6%) 0
Pneumonia 1 (6%) 0
Data are n (%). ACBT = active cycle of breathing techniques,
COPD = chronic obstructive pulmonary disease.
30 minutes per session. The patient was positioned in high
side lying according to the affected side of the lung. If the
patient did not tolerate this position (if signs of respiratory
distress developed), high sitting was preferred. The forward
lean sitting position was used when posterior aspects of the
lung were involved (Bott et al 2001, Pryor and Webber 2002).
Because the active participation of the patient was required,
attention was given to ensure that the patient was not
exhausted and had a comfortable breathing pattern before the
application of treatment.
Data analysis The primary outcome measure was length of
time in need of NIV, which was the total length of time until
the patient was not on NIV during the day at all. Secondary
outcome measures were change in acute physiology score,
change in arterial blood gas values, total duration of NIV,
need for intubation, mortality, and length of stay in the ICU.
A power analysis was performed prior to the study, and a
sample size of 32 (16 patients in each group) was found to be
sufficient, with an 80% power for detecting a minimum
difference of one day (SD = 1 day) in the length of time in
need of NIV, the primary outcome variable.
Statistical analysis was performed using Statistical Package
for Social Sciences (SPSS) version 10.0. Categorical
variables were compared using Chi-square or Fisher’s exact
test, as appropriate. Wilcoxon signed rank test was used for
within-group comparisons, and Mann-Whitney U test for
between-group comparisons of numerical variables.
Friedman’s test was used to analyse duration of the ACBT in
sessions on the first, second, and last days of ICU stay (Green
et al 2000) since minimum ICU stay was found to be 3.2 days
in our study. Repeated measures of analysis of variance was
performed to analyse arterial blood gas values, daily duration
of NIV, pressure support, and tidal volume between the
groups (Green et al 2000, Tabachnick and Fidell 1996).
Statistical significance was defined as a value of p < 0.05.
Results
Thirty-five patients were found to be eligible to the study.
None of the patients had prior experience of the ACBT, and
no patient was excluded from the study due to lack of active
participation. One patient from the control group refused
treatment 1.5 days after admission, and was discharged from
the ICU at his request. Of the remaining 34 patients, 17 were
in the ACBT group and 17 were in the control group. The two
groups were similar with regard to age, APACHE II score,
arterial blood gas values and other characteristics (p > 0.05,
Table 1). There was no significant difference in the
distribution of causes of respiratory failure between the
groups (p = 0.25, Table 2). The use of medical treatment
(bronchodilators, antibiotics, and corticosteroids) did not
differ significantly between the two groups (p > 0.05).
Neither the kind of ventilator nor mode of ventilation used
differed significantly between the two groups (p > 0.05).
Similarly, level of support and tidal volume supplied
throughout the NIV did not differ significantly between the
groups (p > 0.05). There was no significant difference in the
daily duration of NIV on the first (16.6 ± 3.6 hours for ACBT
group vs 16.2 ± 3.9 hours for control group), second (11.1±
5.2 hours for ACBT group vs 14.2 ± 4.9 hours for control
group) or third (13.7 ± 4.1 hours for ACBT group vs 12.3 ±
5.3 hours for control group) days of the ICU stay (p = 0.15).
The mean acute physiology score decreased significantly
from baseline by -1.9 (95% CI -3.6 to -0.2, p = 0.03) in the
ACBT group, and by -2.7 (95% CI -5.5 to 0.2, p = 0.03) in the
control group at ICU discharge. Similarly, arterial pH
increased significantly to normal values from baseline by a
mean of 0.11 (95% CI 0.08 to 0.14, p < 0.001) in the ACBT
group, and by a mean of 0.11 (95% CI 0.08 to 0.15, p < 0.001)
in the control group at ICU discharge. However, changes in
acute physiological score (p = 0.68) and arterial pH (p = 0.76)
were not statistically significant between the groups. The
PaCO
2 
decreased significantly from admission to discharge
by a mean of -21.4 (95% CI -28.2 to -14.6) mmHg in the
ACBT group (p < 0.001), and by a mean of -17.5 (95% CI -
24.9 to -10.0) mmHg in the control group (p = 0.001). As seen
in Figure 2, the reduction of PaCO
2
was larger in the ACBT
group than in the control group but there was no significant
difference between the two groups (p = 0.27).
Although total duration of NIV and length of ICU stay were
shorter in the ACBT group than in the control group, neither
variable was statistically significant (p > 0.05, Table 3). The
mean length of time NIV was required for the ACBT group
was significantly shorter than for the control group (p = 0.03,
Table 3). One patient from ACBT group and one patient from
the control group required endotracheal intubation and
invasive mechanical ventilation 6.5 and five days after the
beginning of the NIV, respectively. Nasal pressure sores were
observed in seven patients from the ACBT group and in six
patients from the control group. Other adverse events were
eye irritation in two patients from the ACBT group and one
patient from control group, and nose bleeding in one patient
from the control group. Patients in both groups were
discharged from the ICU after a successful treatment, and no
patient died during the study period.
There was no significant difference in the duration of ACBT
during the ICU stay (p = 0.36, Table 4). No significant
differences were found in heart rate, blood pressure, or
respiratory rate as an acute response to the application of
ACBT (p > 0.05, Table 4). On the last day of the ICU stay, the
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Table 3. Total duration and length of time requiring non-invasive ventilation, and length of stay in the intensive care unit.
ACBT Control
(n = 17) (n = 17) Difference (95% CI) p value
Total duration of NIV (hours) 64.9 ± 29.7 84.1 ± 36.6 19.3 (1.2 to 37.4) 0.15
Length of time requiring NIV (days) 5.0 ± 2.5 6.7 ± 2.6 1.7 (-0.3 to 3.8) 0.03
Length of ICU stay (days) 8.0 ± 3.9 9.4 ± 4.4 1.3 (-0.5 to 3.1) 0.31
Data are means ± SD. ACBT = active cycle of breathing techniques, NIV = non-invasive ventilation, ICU = intensive care unit.
mean SpO
2 
increased significantly from baseline by 2.6%
(95% CI 0.7 to 4.5%) as an acute response to the ACBT
treatment (p = 0.006, Table 4) despite a non-significant
change in FiO
2
during the treatment (p > 0.05, Table 4).
Discussion
In this study, we showed that inclusion of the ACBT in NIV
application to patients with acute hypercapnic respiratory
failure decreased the length of time NIV was needed by
almost two days. In addition, decrease in PaCO
2
was greater,
the mean ICU stay was 1.3 days less, and the mean duration
of NIV was 19 hours shorter in patients receiving both the
ACBT and NIV. There were no acute adverse responses to the
ACBT treatment in terms of SpO
2
, heart rate, blood pressure,
and respiratory rate. These findings reveal that the inclusion
of the ACBT in the management of patients receiving NIV
could accelerate recovery from acute hypercapnic respiratory
failure without any detrimental effects.
Some studies have suggested undesirable acute effects of
conventional chest physiotherapy on pulmonary function in
patients with acute exacerbations of chronic bronchitis.
Campbell et al (1975) and Wollmer et al (1985) demonstrated
a decrease in forced expiratory volume in one second (FEV
1
)
as an acute response to head-down positioning combined with
chest percussion in patients with acute exacerbations of
chronic bronchitis. Although it is a reliable measure of
respiratory function, use of FEV
1
as an outcome measure in
the acute setting has not been recommended because of its
insensitivity to changes in clinical condition (Bach et al
2001). In another study, Connors et al (1980) showed an acute
reduction in arterial oxygenation with the same treatment in
22 acutely ill patients, including six patients who were
intubated and mechanically ventilated. Despite this finding,
Pryor et al (1990) demonstrated no reduction in arterial
oxygenation during ACBT where chest percussion is
combined with thoracic expansion exercises, and breathing
control are interspersed during the cycle in patients with acute
exacerbation of cystic fibrosis. In addition, Wong (2000)
showed that use of the ACBT improved arterial oxygenation
with resolution of infiltrates in a patient with acute
respiratory failure. Similarly, we showed that the ACBT did
not cause any acute detrimental effects in patients with acute
hypercapnic respiratory failure receiving NIV.
Although various respiratory physiotherapy techniques have
been proposed, to our knowledge only the effect of the PEP
mask in patients with acute respiratory failure receiving NIV
has been investigated in a controlled study. Bellone et al
(2002) investigated the supplementary effect of providing
PEP in addition to assisted cough in patients receiving NIV
due to acute exacerbation of chronic obstructive pulmonary
disease. They showed that a combination of PEP mask and
assisted cough decreased NIV duration, and increased sputum
production as compared to assisted cough alone. Length of
ICU stay did not differ significantly between the groups in
their study.
This study investigated the effects of the use of ACBT in
patients receiving NIV due to acute hypercapnic respiratory
failure. Although the investigation of the mechanisms of the
ACBT in patients receiving NIV was beyond the scope of our
study, the individual effects of three breathing manoeuvers in
the ACBT, most probably enhanced mucociliary clearance,
could be responsible for the findings of this study. Weight or
volume of sputum expectorated is one of the measures that
can be used to determine airway clearance. We did not use
this measure because it is not a reliable indicator of the
effectiveness of airway clearance (Rossman et al 1982).
Hasani et al (1994) showed that unproductive forced
expiration technique improved mucociliary clearance.
A lack of significant difference in arterial blood gas tensions
between the groups could be related to the frequency of the
ACBT application used in this study. The number of
physiotherapists in the ICU determines the frequency of
treatment (Ntoumenopoulos et al. 1991). In our country, like
in most European countries, physiotherapy services could not
be given continuously for 24 hours per day (Norrenberg
2000). Although power analysis was performed to determine
the number of patients for the primary outcome variable, the
length of time requiring NIV, the sample size might still not
be sufficient to detect significant differences in arterial blood
gas values. Furthermore, the sample size was similar to that
used in other single centre controlled studies (Anton et al
2000, Celikel et al 1998). Large samples are difficult to
obtain since NIV can be applied only to certain patients
(Meduri and Spencer 2001, Mehta and Hill 2001), and only
30–35% of ICU patients are suitable for NIV treatment
(Brochard et al 1995, Carlucci et al 2001).
Some limitations of this study should be considered when
interpreting the results. First, the blinding of group
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Table 4. Acute responses to the active cycle of breathing techniques on Day 1, Day 2, and the last day of the stay in the intensive
care unit.
Day 1 Day 2 Last day
Pre-ACBT Post-ACBT Pre-ACBT Post-ACBT Pre-ACBT Post-ACBT
Heart rate (beats/min) 99.4 ± 17.0 100.0 ± 19.6 96.7 ± 17.5 96.2 ± 18.9 93.9 ± 19.0 93.4 ± 19.0
Systolic blood pressure (mmHg) 124.8 ± 19.5 126.7 ± 19.3 129.3 ± 19.4 128.7 ± 19.1 124.2 ± 19.0 128.0 ± 18.9
Diastolic blood pressure (mmHg) 69.4 ± 11.3 68.9 ± 13.5 69.9 ± 10.9 67.8 ± 9.1 73.8 ± 10.3 69.9 ± 14.2
Respiratory rate (breaths/min) 24.8 ± 5.6 24.3 ± 6.4 25.2 ± 6.2 26.9 ± 6.8 23.6 ± 4.3 24.8 ± 4.6
Oxygen saturation (%) 92.0 ± 5.3 91.5 ± 5.4 93.0 ± 3.4 92.2 ± 4.0 91.2 ± 4.1 93.8 ± 3.7*
Fraction of inspired oxygen (%) 31.4 ± 9.5 31.8 ± 9.9 33.7 ± 10.0 33.7 ± 10.0 25.4 ± 3.6 25.4 ± 3.6
Duration of ACBT (min) 18.8 ± 8.4 20.9 ± 7.3 18.2 ± 6.6
Data are means ± SD. ACBT = active cycle of breathing techniques, *Significant difference between Pre-ACBT and Post-ACBT 
(p = 0.006).
assignment by the primary ICU team was not possible, and
this may have introduced a bias. However, an independent
physician took the decisions related to the application of NIV,
and the physiotherapist, who performed the ACBT, was not
involved in the decision-making process related to NIV
outcome (total duration and length of time in NIV, need for
intubation, and length of stay in the ICU). Second, a relatively
higher percentage of the patients with acute exacerbation of
chronic obstructive pulmonary disease in the control group
may have resulted in poorly matched groups. However, there
was no significant difference in the distribution of causes of
respiratory failure between the groups, and group equivalence
in our study was checked by the severity of illness since the
degree of acidosis and APACHE II are the factors determining
the success of NIV (Keenan et al 2003, Liesching et al 2003,
Lightowler et al 2003, Plant and Elliot 2003). Moreover, the
inclusion of patients with a variety of aetiologies for their
acute hypercapnic respiratory failure could reflect common
respiratory physiotherapy practice in the acute care setting.
Conclusion
The results of this study provide evidence that the use of
ACBT in patients with acute hypercapnic respiratory failure
is safe, and it could shorten the length of time required for
NIV. Therefore, it may have positive effects on the
management of these patients. Further studies are needed to
show the effects of application of ACBT in increased
frequency on arterial blood gases in a larger sample size. In
addition, other respiratory physiotherapy techniques besides
PEP mask and ACBT should be investigated in patients with
acute hypercapnic respiratory failure receiving NIV.
Footnotes (a)BiPAP (Respironics Inc, Murrysville, USA). 
(b) ICU ventilator (Model Servo 300, Siemens, Sweden).
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